NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »           NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »          NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »

The In’s and Out’s of Genetic Testing Payment Integrity

In part one of this blog series, we answered common questions posed by medical directors and claims management leaders at health plans. Because accurately reviewing and identifying genetic testing claims payments can be incredibly complex, we continue the conversation with our experts in this blog and turn our focus to the logistics of the payment […]

Case Study: Genetic Test Payment Integrity

Payment Integrity Edits Identify $26.5M in Inappropriate Genetic Testing Payments Driven by the rapid and ongoing increase in the number of genetic tests available on the market, genetic testing spending is projected to increase from $13B in 2020 to $29B by 2026. The growth and complexity of these tests create clinical and payment appropriateness challenges. […]

×